ConductScience.org, home

Paper39340558

Transient MRI changes and neurological deterioration in glioblastoma upon SARS-CoV-2 infection.

Zeyen T and 17 others. J Cancer Res Clin Oncol, 2024. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Transient MRI changes and neurological deterioration in glioblastoma upon SARS-CoV-2 infection. Papers, record 39340558. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39340558

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Transient MRI changes and neurological deterioration in glioblastoma upon SARS-CoV-2 infection.
PubMed
Journal
J Cancer Res Clin Oncol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Case Reports
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.42, provisional
iCite
Revised in PubMed
2024-11-27
PubMed

Authors18

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zeyen TThomas
2Friker LLLea L
3Paech DDaniel
4Schaefer NNiklas
5Weller JJohannes
6Zschernack VValentina
7Layer JPJulian P
8Schneider MMatthias
9Potthoff ALAnna-Laura
10Bernhardt MMarit
11Sanders CChristine
12Kristiansen GGlen
13Hoelzel MMichael
14Gkika EEleni
15Radbruch AAlexander
16Pietsch TTorsten
17Herrlinger UUlrich
18Schaub CChristinahttps://orcid.org/0000-0002-5257-4183

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Brain NeoplasmsMajor topic
COVID-19Major topic
GlioblastomaMajor topic
Magnetic Resonance ImagingMajor topic
SARS-CoV-2Major topic
Humans
Tumor Microenvironment

Source PubMed

Download CSV of topics

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128382534Pseudoprogression, radionecrosis, inflammation or true tumor progression? challenges associated with glioblastoma response assessment in an evolving therapeutic landscape.J Neurooncol2017https://conductscience.org/library/papers/28382534PubMed
238720342Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives.J Hematol Oncol2024https://conductscience.org/library/papers/38720342PubMed
339006516Accelerated tumor progression after COVID-19 infection in patients with glioblastoma: A retrospective case-control study.Neurooncol Pract2024https://conductscience.org/library/papers/39006516PubMed
436079151Cytomegalovirus and Glioblastoma: A Review of the Biological Associations and Therapeutic Strategies.J Clin Med2022https://conductscience.org/library/papers/36079151PubMed
536058935In vitro and in vivo differences in neurovirulence between D614G, Delta And Omicron BA.1 SARS-CoV-2 variants.Acta Neuropathol Commun2022https://conductscience.org/library/papers/36058935PubMed
636790010Pseudoprogression versus true progression in glioblastoma: what neurosurgeons need to know.J Neurosurg2023https://conductscience.org/library/papers/36790010PubMed
736797335Impact of the SARS-CoV-2 pandemic on the survival of patients with high-grade glioma and best practice recommendations.Sci Rep2023https://conductscience.org/library/papers/36797335PubMed
827515827Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastoma.Neuro Oncol2016https://conductscience.org/library/papers/27515827PubMed
929943666Recurrent Glioblastoma Treated with Recombinant Poliovirus.N Engl J Med2018https://conductscience.org/library/papers/29943666PubMed
1035864254Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial.Nat Med2022https://conductscience.org/library/papers/35864254PubMed
1133838625Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas.N Engl J Med2021https://conductscience.org/library/papers/33838625PubMed
1233307200Pseudoprogression versus true progression in glioblastoma patients: A multiapproach literature review: Part 1 - Molecular, morphological and clinical features.Crit Rev Oncol Hematol2021https://conductscience.org/library/papers/33307200PubMed
1334174183Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions.Immunity2021https://conductscience.org/library/papers/34174183PubMed
1437224228Targeted delivery of tumor necrosis factor in combination with CCNU induces a T cell-dependent regression of glioblastoma.Sci Transl Med2023https://conductscience.org/library/papers/37224228PubMed
1538279060Surgical site infections after glioblastoma surgery: boon or bane?J Cancer Res Clin Oncol2024https://conductscience.org/library/papers/38279060PubMed
1627286796Frequent occurrence of therapeutically reversible CMV-associated encephalopathy during radiotherapy of the brain.Neuro Oncol2016https://conductscience.org/library/papers/27286796PubMed
1737238200Brain Volume Changes after COVID-19 Compared to Healthy Controls by Artificial Intelligence-Based MRI Volumetry.Diagnostics (Basel)2023https://conductscience.org/library/papers/37238200PubMed
1828862482Pseudoprogression after glioma therapy: an update.Expert Rev Neurother2017https://conductscience.org/library/papers/28862482PubMed
1937853118Clinical trial links oncolytic immunoactivation to survival in glioblastoma.Nature2023https://conductscience.org/library/papers/37853118PubMed
2027935360The effect of postoperative infection on survival in patients with glioblastoma.J Neurosurg2017https://conductscience.org/library/papers/27935360PubMed

See all 34 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
41498242COVID vaccination and post-infection cancer signals: Evaluating patterns and potential biological mechanisms.Oncotarget2026https://conductscience.org/library/papers/41498242PubMed
40983970Primary leptomeningeal histiocytic lymphoproliferative disorder associated with SARS-CoV-2 brain infection in k18-hACE2 mouse: a case report.Lab Anim Res2025https://conductscience.org/library/papers/40983970PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39340558

GET https://conductscience.org/api/papers/v1/39340558/references?page=2